Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Interest Coverage Ratio (2016 - 2024)

Trinity Biotech's Interest Coverage Ratio history spans 16 years, with the latest figure at 3.41 for Q4 2024.

  • On a quarterly basis, Interest Coverage Ratio rose 110.58% to 3.41 in Q4 2024 year-over-year; TTM through Dec 2024 was 3.27, a 33.98% increase, with the full-year FY2025 number at 0.74, up 66.64% from a year prior.
  • Interest Coverage Ratio hit 3.41 in Q4 2024 for Trinity Biotech, up from 1.43 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for TRIB hit a ceiling of 11.52 in Q1 2024 and a floor of 7.48 in Q3 2020.
  • Historically, Interest Coverage Ratio has averaged 0.59 across 5 years, with a median of 0.22 in 2022.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 587.72% in 2020 and later skyrocketed 1923.82% in 2022.
  • Tracing TRIB's Interest Coverage Ratio over 5 years: stood at 7.41 in 2020, then surged by 97.47% to 0.19 in 2021, then surged by 1923.82% to 3.42 in 2022, then plummeted by 52.74% to 1.62 in 2023, then skyrocketed by 110.58% to 3.41 in 2024.
  • Business Quant data shows Interest Coverage Ratio for TRIB at 3.41 in Q4 2024, 1.43 in Q2 2024, and 11.52 in Q1 2024.